Candel Therapeutics Inc (CADL)

Finanzdaten der Candel Therapeutics Inc-Aktie (CADL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	64.25%26.75	16.28	15.75	13.21	11.18
Research and Development	101.23%19.80	9.84	11.03	8.46	6.99
Interest Income/Expense	0.70%1.58	1.56	1.42	0.16	0.24
Operating Income/Loss	64.25%-26.75	-16.28	-15.75	-13.21	-11.18
Nonoperating Income/Loss	263.80%-12.16	7.42	-13.74	1.94	6.38
	339.06%-38.91	-8.86	-29.50	-11.27	-4.80
Attributable To Parent	339.06%-38.91	-8.86	-29.50	-11.27	-4.80
Basic Average Shares	18.87%74.13	62.36	-	54.89	51.49
Diluted Average Shares	18.87%74.13	62.36	-	54.89	51.49
Basic Earnings Per Share	271.43%-0.52	-0.14	-	-0.21	-0.09
Diluted Earnings Per Share	271.43%-0.52	-0.14	-	-0.21	-0.09